ETFMG Treatments Testing and Advancements ETF (GERM)

NYSEARCA: GERM · IEX Real-Time Price · USD
20.86
+0.39 (1.89%)
Sep 27, 2022 9:44 AM EDT - Market open
1.89%
Assets $22.75M
NAV $20.68
Expense Ratio 0.68%
PE Ratio 12.98
Shares Out 1.10M
Dividend (ttm) $0.11
Dividend Yield 0.53%
Ex-Dividend Date Sep 21, 2022
1-Year Return -51.58%
Volume 1,498
Open 20.30
Previous Close 20.47
Day's Range 20.30 - 20.86
52-Week Low 20.30
52-Week High 41.99
Beta 0.66
Holdings 75
Inception Date Jun 17, 2020

About GERM

The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

Asset Class Equity
Region North America
Issuer ETF Managers Group
Stock Exchange NYSEARCA
Ticker Symbol GERM
Index Tracked Prime Treatments, Testing and Advancements Index

Top 10 Holdings

52.06% of assets
Name Symbol Weight
Quest Diagnostics DGX 6.56%
Alnylam Pharmaceuticals ALNY 6.46%
Laboratory Corporation of America Holdings LH 6.31%
Moderna MRNA 6.02%
BioNTech SE BNTX 5.92%
ETFMG SIT Ultra Short ETF VALT 5.47%
QuidelOrtho QDEL 4.14%
Bio-Rad Laboratories BIO 3.86%
AbCellera Biologics ABCL 3.70%
Zai Lab ZLAB 3.62%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Sep 21, 2022 $0.060 Sep 23, 2022
Jun 22, 2022 $0.050 Jun 24, 2022
Dec 28, 2021 $0.001 Dec 30, 2021
Sep 21, 2021 $0.040 Sep 23, 2021
Jun 22, 2021 $0.060 Jun 24, 2021
Dec 14, 2020 $0.285 Dec 16, 2020
Full Dividend History

News

Biotech ETFs Slip After Novavax Cuts 2022 Guidance

Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares Genom...

Other symbols: IDNASBIOXBI
1 month ago - ETF Trends

Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs

Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in its...

Other symbols: BBHIBBQMRNA
1 month ago - ETF Trends

Pharma & Biotech ETFs at One-Month High: Here's Why

Pharma and biotech ETFs are in great shape and are trading at a one-month high level.

2 months ago - Zacks Investment Research

China ETFs Drop On Audit Enforcement

The first tranche of Chinese ADRs affected by a 2020 law has been released.

Other symbols: CHIHCHIQMCHIMSGRXITK
6 months ago - ETFcom

Biotech ETFs That Outperformed Last Week

Biotech ETFs was the biggest gainer last week.

9 months ago - Zacks Investment Research

Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs

Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.

Other symbols: BBPFBTPBESBIO
9 months ago - Zacks Investment Research

5 Best Sector ETFs of November

Though the broad markets ended the month in red, a few sector ETFs performed remarkably well.

Other symbols: ESPOITBSOXXVCAR
9 months ago - Zacks Investment Research

Bet On COVID-Themed ETFs as New Cases Rise Globally

The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.

Other symbols: EDOCEDUTVIRSWFH
10 months ago - Zacks Investment Research

7 Best ETFs of the First Nine Months of 2021

We highlight seven ETFs from different segments that have outperformed and gained more than 40% in the first nine months of 2021.

1 year ago - Zacks Investment Research

Play COVID-Themed ETFs as US Labor Day Sees Rise in New Cases

The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.

Other symbols: EDOCEDUTVIRSWFH
1 year ago - Zacks Investment Research

Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan

The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.

Other symbols: GNOMIHEVIRSXHE
1 year ago - Zacks Investment Research

6 Best ETF Areas of August

Optimism about corporate earnings, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine, some upbeat economic data points and the passage of the infrastructure bill helped key U.S. equity indexe...

Other symbols: ARGTBDRYBETZBKCHXSD
1 year ago - Zacks Investment Research

5 Must-Watch ETF Charts of Q2 Earnings

Below are five ETFs that have gained from strong earnings results.

Other symbols: BUGIAIRTM
1 year ago - Zacks Investment Research

COVID Biotech ETFs Rise At Fever Pace

ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.

Other symbols: IBBVIRSXBI
1 year ago - ETFcom

ETFs to Buy on Most-Bullish Wall Street Outlook in Two Decades

Wall Street analysts are bullish on stocks in almost two decades with about 56% of all recommendations on S&P 500 firms listed as buys, the highest since 2002.

Other symbols: BLOKFCGREMXXRTXSVM
1 year ago - Zacks Investment Research

Are COVID-Themed ETFs Back in Focus as Delta Variant Fears Rise?

The rest of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

Other symbols: EDOCEDUTVIRSWFH
1 year ago - Zacks Investment Research

5 Sector ETFs That Crushed the Market in April

April proved to be the solid month for the U.S. stock market with all the three major indices hovering near record highs.

Other symbols: AMZACOPXSLXVCLO
1 year ago - Zacks Investment Research

7 Health-Focused ETFs To Buy Now For the Post-Covid Future

The healthcare sector outperformed in the past year due to the pandemic. Here are seven ETFs for your portfolio to look beyond Covid-19.

Other symbols: IBBIHFRYHSBIOXLVARKG
1 year ago - InvestorPlace

The 7 Best-Performing ETFs Money Can Buy In 2021

Here're seven of the most popular ETFs so far in 2021 The post The 7 Best-Performing ETFs Money Can Buy In 2021 appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G A...

1 year ago - InvestorPlace

5 Niche ETFs Dominating the Current Market Rally

We have highlighted five ETFs from different zones that were at the heart of the latest market rally over the past week and will likely to do so if the current trends prevail.

Other symbols: COPXLITREMXSGDJ
1 year ago - Zacks Investment Research

7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic

Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

Other symbols: DHRGILDHOLXIMVTPFEXLV
1 year ago - InvestorPlace

What's in Store for COVID-Themed ETFs as New Cases Rise?

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart p...

Other symbols: EDOCEDUTVIRSWFH
1 year ago - Zacks Investment Research

6 ETF Areas That Are on High Momentum

The first month of 2021 was pretty volatile. While stocks were at their all-time highs in first part of January, some downbeat economic data points as well as the retail trading frenzy in some specific ...

Other symbols: IWMSILJSLVPVPN
1 year ago - Zacks Investment Research

5 Sector ETFs That Outperformed in a Volatile January

The three indices logged in their worst week since October, dropping more than 3% each, sending the Dow Jones and S&P 500 into the red for the first month of 2021.

Other symbols: GAMRPOTXPRNTXRT
1 year ago - Zacks Investment Research

Biotech ETFs extend January gains

Biotech exchange-traded funds rallied Monday as investors continued to monitor the sector and its impact on the coronavirus pandemic. The ETFMG Treatments Testing and Advancement ETF gained 4.6% mid-mor...

Other symbols: CNCRXBI
1 year ago - Market Watch